AI in the IP Department: Achieving the Optimal Balance between Human Intelligence & Artificial Intelligence Webinar
September 9, 2021 The commercial introduction of various AI applications has spurred interest by IP departments in adopting AI tools. It is essential to determine the [...]
mRNA Vaccines: Intellectual Property Landscape
By Cecilia Martin and Drew Lowery Originally published July 28, 2020 The mRNA vaccine space is emerging as a promising alternative to traditional vaccine platforms, as [...]
Who is leading the AI chips IP race? Best practice in IP management
By Bruce Rubinger and Jason Hannon February 12, 2020 AI and its diverse applications (eg, machine learning and deep learning) have seen significant market growth in [...]
Leveraging Cutting Edge Biotechnology Research in Japan For Stronger IP Portfolios and Research Prioritization
By Chie Mueller-Hillebrand Ph.D., David Adamovich Ph.D., and Drew Lowery, Ph.D. December 10, 2020 Japan is [...]
Successful IPRs – Lessons from the Trenches on Several Key Implementation Factors
By Bruce Rubinger and Brendan Sever November 30, 2020 (updated January 12, 2021) Introduction Inter-partes reviews [...]